These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Diabetic cardiomyopathy]. Huang YQ; Wang X; Kong W Sheng Li Ke Xue Jin Zhan; 2010 Feb; 41(1):31-6. PubMed ID: 21417012 [TBL] [Abstract][Full Text] [Related]
4. Early administration of trimetazidine may prevent or ameliorate diabetic cardiomyopathy. Wenmeng W; Qizhu T Med Hypotheses; 2011 Feb; 76(2):181-3. PubMed ID: 20932648 [TBL] [Abstract][Full Text] [Related]
5. [Diabetic cardiomyopathy: concept, heart function, and pathogenesis]. Codinach Huix P; Freixa Pamias R An Med Interna; 2002 Jun; 19(6):313-20. PubMed ID: 12152393 [TBL] [Abstract][Full Text] [Related]
6. Clinical Approach to Diabetic Cardiomyopathy: A Review of Human Studies. Tarquini R; Pala L; Brancati S; Vannini G; De Cosmo S; Mazzoccoli G; Rotella CM Curr Med Chem; 2018; 25(13):1510-1524. PubMed ID: 28685679 [TBL] [Abstract][Full Text] [Related]
7. [Myocardial and coronary vessel dysfunction in diabetes I patients]. Konduracka E; Galicka-Latała D; Piwowarska W; Sieradzki J Przegl Lek; 2002; 59(7):514-8. PubMed ID: 12516240 [TBL] [Abstract][Full Text] [Related]
8. Relationships among microalbuminuria, insulin resistance and renal-cardiac complications in insulin dependent and non insulin dependent diabetes. Nosadini R; Brocco E Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():1-7. PubMed ID: 9288531 [TBL] [Abstract][Full Text] [Related]
9. Association of imaging markers of myocardial fibrosis with metabolic and functional disturbances in early diabetic cardiomyopathy. Jellis C; Wright J; Kennedy D; Sacre J; Jenkins C; Haluska B; Martin J; Fenwick J; Marwick TH Circ Cardiovasc Imaging; 2011 Nov; 4(6):693-702. PubMed ID: 21946703 [TBL] [Abstract][Full Text] [Related]
10. The late complications of diabetes mellitus. Squadrito G; Cucinotta D Ann Ital Med Int; 1991; 6(1 Pt 2):126-36. PubMed ID: 1742148 [TBL] [Abstract][Full Text] [Related]
11. Diabetic cardiomyopathy: recent evidence from mouse models of type 1 and type 2 diabetes. Severson DL Can J Physiol Pharmacol; 2004 Oct; 82(10):813-23. PubMed ID: 15573141 [TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of cardiac dysfunction in diabetes mellitus. Dhalla NS; Pierce GN; Innes IR; Beamish RE Can J Cardiol; 1985; 1(4):263-81. PubMed ID: 3850773 [TBL] [Abstract][Full Text] [Related]
14. Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity. Jia G; Hill MA; Sowers JR Circ Res; 2018 Feb; 122(4):624-638. PubMed ID: 29449364 [TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy. Knapp M; Tu X; Wu R Acta Pharmacol Sin; 2019 Jan; 40(1):1-8. PubMed ID: 29867137 [TBL] [Abstract][Full Text] [Related]
17. Diabetic cardiomyopathy: the search for a unifying hypothesis. Poornima IG; Parikh P; Shannon RP Circ Res; 2006 Mar; 98(5):596-605. PubMed ID: 16543510 [TBL] [Abstract][Full Text] [Related]
20. The role of cardiac lipotoxicity in the pathogenesis of diabetic cardiomyopathy. Ussher JR Expert Rev Cardiovasc Ther; 2014 Mar; 12(3):345-58. PubMed ID: 24552544 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]